1-20 of 27
disease progression
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Barbara Eichhorst, Moritz Fürstenau, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 482–489.
https://doi.org/10.1182/hematology.2019000070
Published: 2019
Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.
https://doi.org/10.1182/hematology.2019000011
Published: 2019
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.
https://doi.org/10.1182/asheducation-2018.1.213
Published: 2018
Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.
https://doi.org/10.1182/asheducation-2018.1.185
Published: 2018
Journal Articles

When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter

Gregory W. Roloff, Elizabeth A. Griffiths
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 35–44.
https://doi.org/10.1182/asheducation-2018.1.35
Published: 2018
Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.
https://doi.org/10.1182/asheducation-2017.1.618
Published: 2017
Journal Articles

Novel approaches to therapy in CML

Ravi Bhatia
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 115–120.
https://doi.org/10.1182/asheducation-2017.1.115
Published: 2017
Journal Articles

Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond

Claire N. Harrison, Donal P. McLornan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 489–497.
https://doi.org/10.1182/asheducation-2017.1.489
Published: 2017
Journal Articles

Uncoding the genetic heterogeneity of myelodysplastic syndrome

R. Coleman Lindsley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 447–452.
https://doi.org/10.1182/asheducation-2017.1.447
Published: 2017
Journal Articles

Looking forward: novel therapeutic approaches in chronic and advanced phases of myelofibrosis

John Mascarenhas
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 329–339.
https://doi.org/10.1182/asheducation-2015.1.329
Published: 2015
Journal Articles

Therapeutic targeting of microenvironment in follicular lymphoma

Grzegorz S. Nowakowski, Stephen M. Ansell
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 169–173.
https://doi.org/10.1182/asheducation-2014.1.169
Published: 2014
Journal Articles

The genomic landscape of acute lymphoblastic leukemia in children and young adults

Charles G. Mullighan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 174–180.
https://doi.org/10.1182/asheducation-2014.1.174
Published: 2014
Journal Articles

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Clive S. Zent, W. Richard Burack
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 119–124.
https://doi.org/10.1182/asheducation-2014.1.119
Published: 2014
Journal Articles

Biology of BM failure syndromes: role of microenvironment and niches

Sophia R. Balderman, Laura M. Calvi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 71–76.
https://doi.org/10.1182/asheducation-2014.1.71
Published: 2014
Journal Articles

Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia

Richard F. Schlenk, Hartmut Döhner
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 324–330.
https://doi.org/10.1182/asheducation-2013.1.324
Published: 2013
Journal Articles

Primary Prophylaxis in Sickle Cell Disease: Is It Feasible? Is It Effective?

Alexis A. Thompson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 434–439.
https://doi.org/10.1182/asheducation-2011.1.434
Published: 2011
Journal Articles

Management of Myelofibrosis

Alessandro M. Vannucchi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 222–230.
https://doi.org/10.1182/asheducation-2011.1.222
Published: 2011
Journal Articles

Many Multiple Myelomas: Making More of the Molecular Mayhem

Marta Chesi, P. Leif Bergsagel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 344–353.
https://doi.org/10.1182/asheducation-2011.1.344
Published: 2011
Journal Articles

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

Jan A. Burger
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 96–103.
https://doi.org/10.1182/asheducation-2011.1.96
Published: 2011